Funds totaling $93,572 were received by the Mylan School of Pharmacy.
- Dr. Patrick Flaherty, associate professor of medicinal chemistry, Mylan School of Pharmacy, $93,572, from Cognition Therapeutics, Inc., for New Piperazines Effecting Abeta Oligomer Displacement from Neuronal Receptors.